Sign in

Jill Olmstead

Chief Human Resources Officer at LendingTreeLendingTree
Executive

About Jill Olmstead

Jill Olmstead is LendingTree’s Chief Human Resources Officer, serving since October 2018; she is 61 and holds an M.A. in Human and Organizational Behavior (Fielding Graduate University) and a B.S. in Business (Clemson University) . Company execution in 2024 included Adjusted EBITDA of $104 million (+33% year over year) with strong Q4 momentum and segment growth, alongside leverage reduction from 5.3x to 3.5x and liquidity to retire remaining 2025 converts—context for pay-for-performance and retention frameworks administered by HR leadership . Pay-versus-performance disclosures show 2024 compensation actually paid tracked with outcomes, while the Company’s 2024 “say-on-pay” received ~97% support, signaling investor endorsement of compensation governance .

Past Roles

OrganizationRoleYearsStrategic impact
Spivey & Olmstead (Charlotte)Founding partner/owner (HR consulting)2010–2018Built HR advisory capability prior to joining LendingTree
Wells Fargo/WachoviaHR leadership positions; EVP, MD & Head of HR for Corporate & Investment Banking~25 years (prior to 2010)Led HR for CIB; deep financial services HR expertise

External Roles

OrganizationRoleYearsStrategic impact
No current public company directorships or committee roles disclosed for Olmstead

Fixed Compensation

MetricFY 2023FY 2024
Base Salary ($)$400,000 $420,000
Target Bonus (% of Salary)60% 60%
Actual Cash Bonus Paid ($)$120,000 $252,000

Key observations:

  • Base salary rose 5% in 2024 to $420K; target bonus stayed at 60% of salary .
  • Actual FY2024 bonus paid equals 60% of salary ($252K), aligned to Company AEBITDA performance and 100% pool funding .

Performance Compensation

ComponentMetricWeightingTargetActualPayoutVesting
Annual Bonus (FY 2024)Corporate AEBITDA100%$118,488,300 pre-bonus AEBITDA $119,000,000 pre-bonus AEBITDA Bonus pool funded at 100% (individual payout per plan) Cash paid in 2025 per program
RSUs (grant date 3/1/2024)Time-vested RSUs30,000 RSUs; grant-date fair value $1,199,400 Vests in 3 equal annual installments starting 3/1/2025
Prior RSUsTime-vested RSUs7,500 RSUs (50/25/25 schedule) 50% on 3/2/2024, then 25% on second and third anniversaries

Program features:

  • NEO annual bonus tied solely to corporate AEBITDA—explicit pay-for-performance design .
  • 2024 equity awards for NEOs (including Olmstead) granted as RSUs to drive retention and alignment; CEO/President also had PSUs with price hurdles, but Olmstead did not receive PSUs .

Equity Ownership & Alignment

ItemDetail
Stock ownership guidelinesNEOs must hold 1.5x–3x base salary; CEO 6x; directors 5x retainer
Hedging/pledgingHedging prohibited; pledging/margin accounts prohibited absent Legal approval
ClawbackDodd-Frank Rule 10D-compliant recovery policy effective Oct 25, 2023 for erroneously awarded incentive pay over prior 3 years

Beneficial ownership (as of April 16, 2025):

  • Shares beneficially owned: 65,003; percentage of class: less than 1% .
  • Includes 40,733 stock options exercisable within 60 days .
  • Shares outstanding: 13,535,034 .

Vested vs. unvested and award composition (as of Dec 31, 2024):

CategoryDetail
Options (exercisable/unexercisable)8,951 exercisable; 4,477 unexercisable at $113.27 strike (3/2/2032); plus other legacy option lots (strikes $218.33, $253.42, $275.82, expirations 2028–2031)
Unvested RSUs2,355 (3/2/2023 grant, 3 equal annual installments); 7,500 (3/2/2024 grant, 50/25/25); 30,000 (3/1/2024 grant, 3 equal annual installments from 3/1/2025)

Insider transactions (vesting/tax withholding, 2025):

DateCodeSharesPricePost-transaction holdings
03/01/2025M (RSU to common)9,99922,893
03/01/2025F (tax)2,981$40.3919,912
03/02/2025M (RSU to common)2,35522,267
03/02/2025F (tax)674$40.3921,593
03/02/2025M (RSU to common)3,75025,343
03/02/2025F (tax)1,073$40.3924,270

Notes:

  • 2023 Form 4s show RSU vesting and F-code tax withholdings—non-discretionary—consistent with typical equity settlement mechanics .
  • No open market discretionary sales disclosed in these filings; F-code entries reflect tax obligations on vest .

Employment Terms

Executive Severance Plan participation (Olmstead) and change-in-control protections:

  • Outside change-in-control involuntary termination: cash severance $420,000; health continuation $17,948; equity acceleration/payout $624,030 (hypothetical at $38.75) .
  • Within 12 months of change-in-control with involuntary termination (double-trigger): cash severance $1,596,000; health continuation $22,435; equity acceleration/payout $1,544,381 (hypothetical at $38.75) .
  • Restrictive covenants (post-termination): non-compete and customer non-solicitation 24 months; employee non-solicitation 18 months; vendor/supplier/contractor non-solicitation 12 months (Bengel has shorter durations; Olmstead falls under standard durational terms) .
  • Hedging prohibited; pledging restrictions enforced; clawback recovery policy adopted Oct 25, 2023 for erroneously awarded incentive compensation .

Compensation Structure Analysis

  • Equity mix increased in 2024: RSU grant $1.199M vs $495K in 2023, reflecting retention/alignment priorities amid return to growth .
  • Cash vs equity: 2024 cash bonus doubled vs 2023 ($252K vs $120K) with 100% pool funding on AEBITDA target achievement (pre-bonus AEBITDA $119M) .
  • Committee explicitly noted Olmstead’s compensation not set below median given her experience and strategic importance—indicating targeted investment in HR leadership .
  • Governance positives: no option repricing; no excise tax gross-ups; strict ownership and clawback policies .

Say-on-Pay & Compensation Committee

  • Say-on-pay support: 2023 ~86% “FOR”; 2024 ~97% “FOR” .
  • Compensation Committee: Steven Ozonian (Chair), G. Kennedy Thompson, Mark Ernst (independent); FW Cook engaged as independent consultant in 2024 and 2025; peer groups updated to reflect marketplace/fintech comparables .

Company Performance Context During Tenure

Metric ($USD)FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024
Revenues$617,736,000 $764,865,000 $1,106,603,000 $909,990,000 $1,098,499,000 $984,992,000 $672,502,000 $900,219,000
EBITDA*$75,037,000*$100,228,000*$137,744,000*$54,255,000*$47,575,000*$2,949,000*$21,859,000*$59,621,000*

*Values retrieved from S&P Global.

Additional qualitative performance:

  • 2024: AEBITDA $104M (+33%) with Insurance segment revenue $549M (+120%) and segment profit $159M (+54%); Consumer and Home segments stabilized/improving; leverage reduced, liquidity preserved, and capital structure optimization underway .

Investment Implications

  • Alignment: Strong ownership/anti-hedging/anti-pledging and clawback regime, plus RSU-heavy grants for NEOs, indicate durable alignment; Olmstead’s 2024 RSU grant and ongoing vesting suggest retention priorities without aggressive option-based risk .
  • Retention risk: Robust double-trigger change-in-control protections and lengthy non-compete/non-solicit terms reduce near-term attrition risk; hypothetical CIC cash and equity payouts (~$3.16M total) are material but standard for senior officers and tied to termination post-CIC .
  • Selling pressure: Recent Form 4 activity shows RSU conversions with F-code tax withholding, not discretionary open-market sales—limited indication of voluntary selling pressure .
  • Pay-for-performance: Annual bonus fully tied to corporate AEBITDA; 2024 pool funded at 100% after target met—clear linkage that supports governance credibility and reduces pay inflation risk; high say-on-pay support corroborates this .
  • Execution risk: Company is re-accelerating growth after industry dislocation; HR leadership continuity (since 2018) across cycles is a stabilizer for talent strategy, but macro-sensitive segments (Home/Consumer) remain exposure points; monitoring RSU vesting cadence and any 10b5-1 plans can flag future transactional activity .

Sources: LendingTree 2025 and 2024 DEF 14A proxy statements; SEC Form 4 filings for Jill Olmstead; S&P Global financials via tool.